Первая клетка. И чего стоит борьба с раком до последнего

Pienta K. et al. The Cancer Diaspora: Metastasis Beyond the Seed and Soil Hypothesis. Clinical Cancer Research. 19, no. 21 (2013). doi:10.1158/1078–0432. CCR-13–2158.

McGranahan N., Swanton Ch. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 168 (2017): 631.

Giam M., Rancati G. Aneuploidy and Chromosomal Instability in Cancer: A Jackpot to Chaos. Cell Division. 10 (2015): 3.

How Well Do We Understand the Relation Between Incorrect Chromosome Number and Cancer? EurekAlert! www.eurekalert.org/pub_releases/2017–01/cshl-hwd011117.php

Sheltzer J. M. et al. Single-Chromosome Gains Commonly Function as Tumor Suppressors. Cancer Cell. 31, no. 2 (2017): 240–255.

Ansari D. Pancreatic Cancer and Thromboembolic Disease, 150 Years After Trousseau. Hepatobiliary Surgery and Nutrition. 4, no. 5 (2015): 325–335.

Campisi J. Aging, Cellular Senescence, and Cancer. Annual Review of Physiology. 75 (2013): 685–705.

Lee S., Lee J-S. Cellular Senescence: A Promising Strategy for Cancer Therapy. BMB Reports. 52, no. 1 (2019): 35–41.

Lan W., Miao Y. Autophagy and Senescence. Senescence Signalling and Control in Plants. (2019): 239–253.

Franceschi C., Campisi J. Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases. Journals of Gerontology: Series A. 69, supplement 1 (2014): S4–S9.

Harley C. B., Villeponteau B. Telomeres and Telomerase in Aging and Cancer. Current Opinion in Genetics & Development. 5, no. 2 (1995): 249–255.

Blackburn E., Epel E. The Telomere Effect: A Revolutionary Approach to Living Younger, Healthier, Longer. New York: Grand Central Publishing, 2017.

Steensma D. et al. Clonal Hematopoiesis of Indeterminate Potential and Its Distinction from Myelodysplastic Syndromes. Blood. 126 (2015): 9–16.

Jaiswal S. et al. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes. New England Journal of Medicine. 371 (2014): 2488–2498.

Bertamini L. et al. Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Patients with Coronary Artery Disease and in Centenarians: Further Clues Linking CHIP with Cardiovascular Risk. Blood. 130 (2017): 1144.

Thomas H. Mutation and Clonal Selection in the Ageing Oesophagus. Nature Reviews Gastroenterology & Hepatology. 16 (2019): 139.

Martincorena I. et al. Somatic Mutant Clones Colonize the Human Esophagus with Age. Science. 362 (2018): 911–917.

Yokoyama A. et al. Age-Related Remodelling of Oesophageal Epithelia by Mutated Cancer Drivers. Nature. 565 (2019): 312–317.

Malcovati L. et al. Clinical Significance of Somatic Mutation in Unexplained Blood Cytopenia. Blood. 129 (2017): 3371–3378.

Fialkow P. J. et al. Evidence for a Multistep Pathogenesis of Chronic Myelogenous Leukemia. Blood. 58 (1981): 158–163.

Gilliland G. D. Nonrandom X–Inactivation Patterns in Normal Females: Lyonization Ratios Vary with Age. Blood. 88, no. 1 (1996): 59–65.

Raza A. Consilence Across Evolving Dysplasias Affecting Myeloid, Cervical, Esophageal, Gastric and Liver Cells: Common Themes and Emerging Patterns. Leukemia Research. 24, no. 1 (2000): 63–72.

Глава 3. Леди Н

Montoro J. et al. Improving Treatment for Myelodysplastic Syndromes Patients. Current Treatment Options in Oncology. 19 (2018): 66.